Novel Histologic Categorization Based on Lauren Histotypes Conveys Prognostic Information for Gastroesophageal Junction Cancers-Analysis from a Large Single Center Cohort in Germany.
Lauren histotype
gastric/gastroesophageal cancer
perioperative chemotherapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
15 Mar 2021
15 Mar 2021
Historique:
received:
25
01
2021
revised:
21
02
2021
accepted:
11
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
4
4
2021
Statut:
epublish
Résumé
Adenocarcinoma of the gastroesophageal junction (AEG) ranks among the most common cancers in the Western world with increasing incidence. However, the prognostic influence and applicability of the Lauren classification was not examined in detail before. The purpose of this analysis was to analyze the oncologic outcomes of GE-junction cancer related to the Lauren histotype in a large single center cohort. Data from the prospectively documented database of the Klinikum Rechts der Isar (TUM School of Medicine) for patients undergoing curatively intended oncologic resection for GE-junction cancer between 1984 and 2018 were extracted. Univariate and multivariate regression analyses were performed to identify predictors for overall survival. Kaplan-Meier analyses were done to investigate the survival rates according to the Lauren histotype. After identification of two distinct histologic categories with prognostic implications, propensity score matching (PSM) was performed to balance for confounders and evaluate its oncologic outcomes retrospectively. In the time period indicated, 1710 patients were treated for GE-junction cancer. Exclusion criteria were: R2-resections (
Identifiants
pubmed: 33804009
pii: cancers13061303
doi: 10.3390/cancers13061303
pmc: PMC8002040
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Histopathology. 2020 Jan;76(2):182-188
pubmed: 31433515
Nature. 2017 Jan 12;541(7636):169-175
pubmed: 28052061
Acta Pathol Microbiol Scand. 1965;64:31-49
pubmed: 14320675
Ann Surg. 2018 Jan;267(1):105-113
pubmed: 27759618
Popul Health Manag. 2013 Feb;16(1):35-45
pubmed: 22788834
Ann Surg. 2009 Dec;250(6):878-87
pubmed: 19855261
J Clin Oncol. 2011 May 1;29(13):1715-21
pubmed: 21444866
J Dig Dis. 2020 Dec;21(12):674-686
pubmed: 32975049
Acta Pathol Jpn. 1982;32 Suppl 2:329-47
pubmed: 6765003
Med Decis Making. 2009 Nov-Dec;29(6):661-77
pubmed: 19684288
N Engl J Med. 2006 Jul 6;355(1):11-20
pubmed: 16822992
J Surg Oncol. 2020 Apr;121(5):795-803
pubmed: 31773740
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Surg Oncol. 2020 Jun;121(7):1084-1089
pubmed: 32153051
Eur J Cancer. 2017 May;76:27-35
pubmed: 28262585
J Clin Oncol. 2010 Dec 10;28(35):5210-8
pubmed: 21060024
Am J Surg Pathol. 2011 Oct;35(10):1512-22
pubmed: 21934477
Multivariate Behav Res. 2011 May;46(3):399-424
pubmed: 21818162
Stat Med. 2015 Dec 10;34(28):3661-79
pubmed: 26238958
Eur J Cancer. 2013 Oct;49(15):3149-58
pubmed: 23800671
Gastric Cancer. 2019 Jan;22(1):1-9
pubmed: 30167905
J Gastrointest Oncol. 2017 Feb;8(1):148-163
pubmed: 28280619
Br J Cancer. 2017 Sep 5;117(6):775-782
pubmed: 28765618
Lancet. 2019 May 11;393(10184):1948-1957
pubmed: 30982686